Loading clinical trials...
Loading clinical trials...
Open-label, long-term extension study available to participants who have completed CNMAu8.201.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Clene Nanomedicine
Collaborators
NCT05344469 · Relapsing Multiple Sclerosis
NCT07426991 · Multiple Sclerosis, Remitting-Relapsing Multiple Sclerosis, and more
NCT06433752 · Relapsing Multiple Sclerosis, Multiple Sclerosis
NCT06617793 · Relapsing Multiple Sclerosis
NCT04047628 · Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, and more
Sydney Brain Mind Centre
Camperdown, New South Wales
John Hunter Hospital
New Lambton Heights, New South Wales
Princess Alexandra Hospital
Woolloongabba, Queensland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions